Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Revelation Biosciences, Inc. REVB

Full chart Compare

Set alert

4.11 USD +0.17 (+4.31%)

At closeNov 10, 2026, 4:05 AM EST

4.11 0.00 0.00%

Pre-market · Nov 10, 4:05 AM ET

3.98 Day range 4.50

3.08 52-week range 40.60

YTD: +28.44%
1 year: -1.20%

News

4 days ago benzinga.com Revelation Biosciences Q3 EPS $(5.92) Beats $(6.16) Estimate Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(5.92) per share which beat the analyst consensus estimate of $(6.16) by 3.9 percent. This is a 88.04 percent increase over losses…
3 weeks ago benzinga.com Revelation Biosciences Announces 1-For-7 Reverse Stock Split, Effective Oct. 20 Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, announced today